Publications by authors named "O Oudar"

Article Synopsis
  • The study investigates the expression of Syndecan-1 (SDC-1), a heparan sulfate proteoglycan, in relation to thoracic aortic aneurysm (TAA) pathology.
  • Human TAA specimens showed a significant increase in SDC-1 mRNA (3.6-fold) and protein (2.3 times) compared to healthy tissues, mainly expressed by smooth muscle cells.
  • Despite these increases, SDC-1 does not appear to influence the progression or rupture of TAA, suggesting it could serve as a potential biomarker for the disease instead.
View Article and Find Full Text PDF

Atherosclerosis, in the ultimate stage of cardiovascular diseases, causes an obstruction of vessels leading to ischemia and finally to necrosis. To restore vascularization and tissue regeneration, stimulation of angiogenesis is necessary. Chemokines and microRNAs (miR) were studied as pro-angiogenic agents.

View Article and Find Full Text PDF

Peripheral arterial disease results from the chronic obstruction of arteries leading to critical hindlimb ischemia. The aim was to develop a new therapeutic strategy of revascularization by using biodegradable and biocompatible polysaccharides-based microparticles (MP) to treat the mouse hindlimb ischemia. For this purpose, we deliver the pro-angiogenic chemokine Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)/CCL5 in the mouse ischemic hindlimb, in solution or incorporated into polysaccharide-based microparticles.

View Article and Find Full Text PDF

Herein we investigate the structure/function relationships of fucoidans from to analyze their pro-angiogenic effect and cellular uptake in native and glycosaminoglycan-free (GAG-free) human endothelial cells (HUVECs). Fucoidans are marine sulfated polysaccharides, which act as glycosaminoglycans mimetics. We hypothesized that the size and sulfation rate of fucoidans influence their ability to induce pro-angiogenic processes independently of GAGs.

View Article and Find Full Text PDF

Induction of angiogenesis is a potential treatment for chronic ischemia. Low molecular weight fucoidan (LMWF), the sulfated polysaccharide from brown seaweeds, has been shown to promote revascularization in a rat limb ischemia, increasing angiogenesis in vivo. We investigated the potential role of two heparan sulfate (HS) metabolism enzymes, exostosin-2 (EXT2) and heparanase (HPSE), and of two HS-membrane proteoglycans, syndecan-1 and -4 (SDC-1 and SDC-4), in LMWF induced angiogenesis.

View Article and Find Full Text PDF